Similarly to cell volume changes, AQP3 silencing resulted in significant reversion of nucleoside-induced cell growth inhibition in the breast cancer cell line MCF7, and to a lesser extent in the colon cancer cell line HT29 after treatment with 5′-DFUR. Here, AQP3 is linked to malignant colon neoplasm.